CN Patent

CN111228278A — 奥贝胆酸的制备、用途和固体形式

Assigned to Intercept Pharmaceuticals Inc · Expires 2020-06-05 · 6y expired

What this patent protects

本申请涉及奥贝胆酸的制备、用途和固体形式。本申请涉及奥贝胆酸： 或其药学上可接受的盐、溶剂合物或氨基酸缀合物。奥贝胆酸可用于治疗或预防FXR介导的疾病或病况、心血管疾病或胆汁郁积性肝病，并且可用于降低HDL胆固醇、降低哺乳动物的甘油三酯或抑制纤维变性。本发明还涉及奥贝胆酸的合成方法。

USPTO Abstract

本申请涉及奥贝胆酸的制备、用途和固体形式。本申请涉及奥贝胆酸： 或其药学上可接受的盐、溶剂合物或氨基酸缀合物。奥贝胆酸可用于治疗或预防FXR介导的疾病或病况、心血管疾病或胆汁郁积性肝病，并且可用于降低HDL胆固醇、降低哺乳动物的甘油三酯或抑制纤维变性。本发明还涉及奥贝胆酸的合成方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN111228278A
Jurisdiction
CN
Classification
—
Expires
2020-06-05
Drug substance claim
No
Drug product claim
No
Assignee
Intercept Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.